Mesenchymal stem cells and hematopoietic stem cell transplantation

被引：63

作者：

Fibbe, WE ^{[1
]}

Noort, WA ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Hematol, Lab Expt Hematol, NL-2333 AA Leiden, Netherlands

来源：

HEMATOPOIETIC STEM CELLS 2002: GENETICS AND FUNCTION | 2003年 / 996卷

关键词：

mesenchymal stem cells; stromal cells; stem cell transplantation; hematopoietic stem cells; engraftment;

D O I：

10.1111/j.1749-6632.2003.tb03252.x

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Techniques have recently beome available to isolate and grow mesenchymal progenitors and to manipulate their growth under defined in vitro culture conditions. As a result mesenchymal stem cells can be rapidly expanded to numbers that are required for clinical application. This has allowed the clinical testing of culture-expanded MSCs in the context of hematopoietic stem cell transplantation. In this paper we discuss the role of MSCs in hematopoietic engraftment after transplantation.

引用

页码：235 / 244

页数：10

共 45 条

[1] Allen T D, 1990, Immunol Ser, V49, P1
[2] Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation
Almeida-Porada, G
Porada, CD
Tran, N
Zanjani, ED
[J]. BLOOD, 2000, 95 (11) : 3620 - 3627
[3] The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells
Barry, F
Boynton, R
Murphy, M
Zaia, J
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (02) : 519 - 524
[4] The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)
Barry, FP
Boynton, RE
Haynesworth, S
Murphy, JM
Zaia, J
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) : 134 - 139
[5] Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
Bartholomew, A
Sturgeon, C
Siatskas, M
Ferrer, K
McIntosh, K
Patil, S
Hardy, W
Devine, S
Ucker, D
Deans, R
Moseley, A
Hoffman, R
[J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) : 42 - 48
[6] Stromal cells retard the differentiation of CD34+CD38low/neg human primitive progenitors exposed to cytokines independent of their mitotic history
Bennaceur-Griscelli, A
Pondarré, C
Schiavon, V
Vainchenker, W
Coulombel, L
[J]. BLOOD, 2001, 97 (02) : 435 - 441
[7] Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
Campagnoli, C
Roberts, IAG
Kumar, S
Bennett, PR
Bellantuono, I
Fisk, NM
[J]. BLOOD, 2001, 98 (08) : 2396 - 2402
[8] CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
[9] Mesenchymal stem cells: Biology and potential clinical uses
Deans, RJ
Moseley, AB
[J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) : 875 - 884
[10] Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion
Devine, SM
Bartholomew, AM
Mahmud, N
Nelson, M
Patil, S
Hardy, W
Sturgeon, C
Hewett, T
Chung, T
Stock, W
Sher, D
Weissman, S
Ferrer, K
Mosca, J
Deans, R
Moseley, A
Hoffman, R
[J]. EXPERIMENTAL HEMATOLOGY, 2001, 29 (02) : 244 - 255

← 1 2 3 4 5 →